United States Influenza Vaccines Market Research Report 2023: An $8.347 Billion Market by 2031 – Industry Trends, Share, Size, Growth, Opportunities and Forecasts 2014-2031 – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “United States Influenza Vaccines Market Size, Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2031” report has been added to ResearchAndMarkets.com’s offering. The influenza vaccines market in the United States was valued at US$ 3,962 million in 2022 and is expected to reach US$ 8,347 million by 2031, registering a CAGR of 8.6% … [Read more…]

$38.879 Billion Heart Failure Devices Markets – Global Forecast to 2029 – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Heart Failure Devices Global Market – Forecast To 2029” report has been added to ResearchAndMarkets.com’s offering. The heart failure devices global market expected to grow at high single-digit CAGR from 2022 to 2029 to reach $38,879.9 million by 2029. Factors such as increasing incidence of heart failure diseases, technological advancement in heart failure … [Read more…]

Median Technologies Reports Full-year 2022 Results and Business Indicators for the First Quarter Of 2023

Further double-digit growth for the Company in 2022: revenue up 16% compared with 2021 (€23.7 million vs. €20.5 million). Revenue of €5.6 million and order backlog at €62 million in Q1 2023. Cash and cash equivalents of €13.1 million at March 31, 2023. Company financing horizon confirmed for December 2023. Advanced discussions with long-standing shareholders … [Read more…]

Poxel Announces Multiple TWYMEEG® (Imeglimin) Abstracts Accepted for Oral Presentation

Nine Imeglimin abstracts to be presented at the 66th Annual Meeting of the Japanese Diabetes Society LYON, France–(BUSINESS WIRE)–Regulatory News: POXEL SA (Euronext: POXEL – FR0012432516) (Paris:POXEL), a clinical stage biopharmaceutical company developing innovative treatments for serious chronic diseases with metabolic pathophysiology, including non-alcoholic steatohepatitis (NASH) and rare metabolic disorders, announced today that nine abstracts … [Read more…]

Global Pharmacy Automation Market Report 2023: Increasing Healthcare Spending and Rise of E-Pharmacy Drives Growth – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Global Pharmacy Automation Market: Analysis by Product, End-user, Region, Size and Trends with Impact of COVID-19 and Forecast up to 2028” report has been added to ResearchAndMarkets.com’s offering. The global pharmacy automation market was valued at US$5.90 billion and is expected to grow to US$9.76 billion by 2028. The term “Pharmacy Automation” refers … [Read more…]

IQVIA Named a Leader in Everest Group Life Sciences Customer Experience Platforms PEAK Matrix® Assessment 2023

RESEARCH TRIANGLE PARK, N.C.–(BUSINESS WIRE)–IQVIA™ (NYSE:IQV), a leading global provider of advanced analytics, technology solutions and clinical research services to the pharmaceutical and broader life sciences industry, today announces the company has been recognized as a Leader in Customer Experience Platforms (CXP) by Everest Group for its Orchestrated Customer Engagement (OCE) platform. The IQVIA OCE … [Read more…]

Vibrent Health Announces Publication of a Peer Reviewed Scientific Paper for a Study Using Exclusively Digital Methods for Data Collection to Study COVID-19’s Impact

Study led by an academic-industry collaboration proves viability to remotely recruit and engage participants for ongoing data collection in infectious disease research FAIRFAX, Va.–(BUSINESS WIRE)–Vibrent Health, a leading software-as-a-service company in the field of precision health research, announced today the publication of a methods paper in JMIR Formative Research (JFR). The prospective cohort study is … [Read more…]

Incyte Announces European Commission Approval of Opzelura® (ruxolitinib) Cream for the Treatment of Non-Segmental Vitiligo with Facial Involvement in Adults and Adolescents

Opzelura® (ruxolitinib) Cream is the first approved treatment in the European Union (EU) to address repigmentation in non-segmental vitiligo Phase 3 data supporting the approval show treatment with Opzelura resulted in improved facial and total body repigmentation, sustained and continued improvements with longer duration of treatment WILMINGTON, Del.–(BUSINESS WIRE)–$INCY #AAD2022–Incyte (Nasdaq:INCY) today announced that the … [Read more…]

“Helping our most vulnerable is what we do,” Say Hospital Staff Donating to the Ottawa Mission (Today) Thursday

OTTAWA, Ontario–(BUSINESS WIRE)–Front-line hospital registered practical nurses, personal support workers, porters, clerical, and other staff from across Ontario in Ottawa for a special bargaining conference are giving back beyond the hospital walls with a large donation to the Ottawa Mission, (today) Thursday, April 20. The more than 200 hospital leaders with the Canadian Union of … [Read more…]

EMIT IMAGING Collaborates with MIT Koch Institute for Integrative Cancer Research to Enhance Cryo-Fluorescence Tomography Technology

BALTIMORE–(BUSINESS WIRE)–EMIT IMAGING, Inc. (“EMIT”), the leader in Cryo-Fluorescence Tomography (CFT), is proud to announce a project with the MIT Koch Institute for Integrative Cancer Research to enhance EMIT’s novel 3D imaging technology. The project will incorporate the Koch Institute’s research-based experiences into CFT workflow and method improvements, allowing for greater accuracy and efficiency in … [Read more…]